NEUP
Neuphoria Therapeutics Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$3.70
−0.40%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.68x
- Price / sales
- -1.91x
- Price / cash flow
- 0.34x
Enterprise value
- Enterprise value
- $590.4K
- EV / sales
- -0.06x
- EV / EBITDA
- -0.03x
- EV / EBIT
- -0.02x
- Market cap
- $20.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026